Pharvaris (PHVS) Interest Coverage Ratio (2021 - 2026)
Pharvaris' (PHVS) quarterly Interest Coverage Ratio came in at 0.0 in Q3 2024, down 99.97% on a QoQ basis from 1.0 in Q4 2023.
Analysis
Pharvaris (PHVS) Interest Coverage Ratio (2021 - 2026) Analysis & Trends
Pharvaris (PHVS) has 5 years of Interest Coverage Ratio data on file, last reported at 0.0 in Q3 2024.
- Quarterly Interest Coverage Ratio changed N/A year-over-year to 0.0 in Q3 2024, while the trailing twelve-month figure through Sep 2024 was 241.5 (down 100.0% YoY) and the FY2023 annual result came in at 0.0, up 100.0% from the prior year.
- Interest Coverage Ratio eased to 0.0 in Q3 2024, from 1.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 1149.68 in Q4 2022 to a low of 1453.56 in Q4 2021.
- A 5-year average of 65.76 and a median of 25.8 in 2021 frame the typical range for Interest Coverage Ratio.
- The widest YoY moves for Interest Coverage Ratio: up 184.09% in 2022, down 407.76% in 2022.
- Tracing PHVS's Interest Coverage Ratio over 5 years: stood at 135.02 in 2020, then sank by 976.57% to 1453.56 in 2021, then surged by 179.09% to 1149.68 in 2022, then sank by 99.91% to 1.0 in 2023, then sank by 99.97% to 0.0 in 2024.
- The last three Interest Coverage Ratio figures came in at 0.0 (Q3 2024), 1.0 (Q4 2023), and 1149.68 (Q4 2022), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | -493.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -21.24 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 8.18 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 2.82 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 1.42 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.08 |
| 10 | Pharvaris | 2.10 Bn | 1.73 Bn | 85,072.10 | -13.32 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.32 |
| Mar 31, 2026 | -8.28 |
| Dec 31, 2025 | -115.71 Mn |
| Sep 30, 2025 | -6.70 |
| Jun 30, 2025 | 9.23 |
| Mar 31, 2025 | 10.95 |
| Dec 31, 2024 | 8.69 Mn |
| Sep 30, 2024 | 10.59 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | -13.66 |
| Dec 31, 2023 | 0.00 |
| Sep 30, 2023 | -9.53 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 14.10 |
| Dec 31, 2022 | 140.59 |
| Sep 30, 2022 | -1.95 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | -5.71 |
| Jun 30, 2021 | 6.14 |
| Mar 31, 2021 | -2.04 |